The influence of inflation rate on the hematologic and hemodynamic effects of intermittent pneumatic calf compression for deep vein thrombosis prophylaxis

Journal of Vascular Surgery

Volumn 44, Issue 5, 2006, Pages 1039-1045

  Morris, Rhys J ^a   Giddings, John C ^a   Ralis, Heather M ^a   Jennings, Gwyneth M ^a   Davies, Delyth A ^a   Woodcock, John P ^a   Dunstan, Frank D J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR; PROCOAGULANT; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CUFF; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; FEMORAL VEIN; FIBRINOLYSIS; HEMODYNAMICS; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VENOUS BLOOD; VOLUNTEER;

ADULT; BLOOD COAGULATION; BLOOD FLOW VELOCITY; FEMORAL VEIN; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; MALE; REFERENCE VALUES; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 33846255468     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.06.016     Document Type: Article

References (41)

1. Virchow R.L.K. Die Verstopfung den Lungenarterie und ihre Folgen. Beitr Exper Path Physiol 2 (1846) 1
2. Morris Rh.J., and Woodcock J.P. Evidence-based compression: Prevention of stasis and deep vein thrombosis. Ann Surg 239 (2004) 162-171
3. Breddin H.K. Prophylaxis and treatment of deep-vein thrombosis. Semin Thromb Hemost 26 Suppl.1 (2000) 47-52
4. Pandolfi M., Nilsson I.M., Robertson B., and Isacson S. Fibrinolytic activity of human veins. Lancet ii (1967) 127-128
5. Allenby F., Boardman L., Pflug J.J., and Calnan J.S. Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet ii (1973) 1412-1414
6. Knight M.T., and Dawson R. Effect of intermittent compression of the arms on deep venous thrombosis in the legs. Lancet ii (1976) 1265-1268
7. O'Brien T.E., Woodford M., and Irving M.H. The effect of intermittent compression of the calf on the fibrinolytic responses in the blood during a surgical operation. Surg Gynecol Obstet 149 (1979) 380-384
8. Tarnay T.J., Rohr P.R., Davidson A.G., Stevenson M.M., Byars E.F., and Hopkins G.R. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous thrombosis. Surgery 88 (1980) 489-496
9. Sinclair M.E., Simpson P., Marshall F.P., and Lockyer J.A. Effect of varying methods of upper limb occlusion on fibrinolytic activity in man. Br J Anaesth 56 (1984) 175-177
10. Salzman E.W., McManama G.P., Shapiro A.H., Robertson L.K., Donovan A.S., Blume H.W., et al. Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression. Ann Surg 206 (1987) 636-641
11. Inada K., Koike S., Shirai N., Matsumoto K., and Hirose M. Effects of intermittent pneumatic leg compression for prevention of postoperative deep venous thrombosis with special reference to fibrinolytic activity. Am J Surg 155 (1988) 602-605
12. Kessler C.M., Hirsch D.R., Jacobs H., MacDougall R., and Goldhaber S.Z. Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation. Blood Coagul Fibrinolysis 7 (1996) 437-446
13. Christen Y., Wutschert R., Weimer D., de Moerloose P., Kruithof E.K., and Bounameaux H. Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activity. Blood Coagul Fibrinolysis 8 (1997) 185-190
14. Comerota A.J., Chouhan V., Harada R.N., Sun L., Hosking J., Veermansunemi R., et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 226 (1997) 306-313
15. Kosir M.A., Schmittinger L., Barno-Winarski L., Duddella P., Pone M., and Perales A. Prospective double-arm study of fibrinolysis in surgical patients. J Surg Res 74 (1998) 96-101
16. Chouhan V.D., Comerota A.J., Sun L., Harada R., Gaughan J.P., and Rao A.K. Inhibition of tissue factor pathway during intermittent pneumatic compression: A possible mechanism for antithrombotic effect. Arterioscler Thromb Vasc Biol 19 (1999) 2812-2817
17. Labropoulos N., Stanley S.K., Kang S.S., Mansour A.M., Fareed J., Littooy F.N., et al. The effects of intermittent pneumatic compression on systemic and local fibrinolysis. Vasc Surg 33 (1999) 211-218
18. Cahan M.A., Hanna D.J., Wiley L.A., Cox D.K., and Killewich L.A. External pneumatic compression and fibrinolysis in abdominal surgery. J Vasc Surg 32 (2000) 537-543
19. Killewich L.A., Cahan M.A., Hanna D.J., Murakami M., Uchida T., Wiley L.A., et al. The effect of external pneumatic compression on regional fibrinolysis in a prospective randomized trial. J Vasc Surg 36 (2002) 953-958
20. Macaulay W., Westrich G., Sharrock N., Sculco T.P., Jhon P.H., Peterson M.G., et al. Effect of pneumatic compression on fibrinolysis after total hip arthroplasty. Clin Orthop 399 (2002) 168-176
21. Murakami M., Wiley L.A., Cindrick-Pounds L., Hunter G.C., Uchida T., and Killewich L.A. External pneumatic compression does not increase urokinase plasminogen activator after abdominal surgery. J Vasc Surg 36 (2002) 917-921
22. Giddings J.C., Morris RhJ., Ralis H.M., Jennings G.M., Davies D.A., and Woodcock J.P. Systematic haemostasis after intermittent pneumatic compression: Clues for the investigation of DVT prophylaxis and travellers thrombosis. Clin Lab Haematol 26 (2004) 269-273
23. Giddings J.C. Molecular genetic and immunoanalysis in blood coagulation (1988), Ellis Horwood Series, Chichester
24. Miyata T., Funatsu A., and Kato H. Chemical cross-linking of activated coagulation factor VII with soluble tissue factor: calcium ions are not essential for full amidolytic activity of the factor VIIa-tissue factor complex after complex formation. J Biochem 117 (1995) 836-844
25. Nonami K., Yamamoto M., Tanaka T., Miyata T., Giddings J.C., Yoshioka A., et al. Plasma levels of factor VIIa are very low in neonates and infants. Thromb Haemost 79 (1998) 689-690
26. Haaland A.K., Skjønsberg O.H., Været A., Ruyter R., and Godal H.C. A novel principle for assessment of stimulated fibrinolysis. Thromb Res 62 (1991) 725-735
27. Vanek V.W. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. Am Surg 64 (1998) 1050-1058
28. Kamm R.D., Butcher R., Froelich J., Johnson M., Salzman E., Shapiro A., et al. Optimisation of indices of external pneumatic compression for prophylaxis against deep vein thrombosis: radionuclide gated imaging studies. Cardiovasc Res 20 (1986) 588-596
29. Mühe E. Intermittent sequential high-pressure compression of the leg: a new method of preventing deep vein thrombosis. Am J Surg 147 (1984) 781-785
30. Anglen J.O., Goss K., Edwards J., and Huckfeldt R.E. Foot pump prophylaxis for deep venous thrombosis: the rate of effective usage in trauma patients. Am J Orthop 27 (1998) 580-582
31. Cornwell III E.E., Chang D., Velmahos G., Jindal A., Baker D., Phillips J., et al. Compliance with sequential compression device prophylaxis in at-risk trauma patients: a prospective analysis. Am Surg 68 (2002) 470-473
32. Jacobs D.G., Piotrowski J.J., Hoppensteadt D.A., Salvator A.E., and Fareed J. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results. J Trauma 40 (1996) 710-717
33. Bouma B.N., and Meijers J.C. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R). Semin Hematol 41 1 Suppl (2004) 13-19
34. Hashimoto M., Yamashita T., Oiwa K., Watanabe S., Giddings J.C., and Yamamoto J. Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles. Thromb Haemost 87 (2002) 110-113
35. Hashimoto M., Oiwa K., Matsuo O., Ueshima S., Okada K., Okada Y., et al. Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model. Thromb Haemost 89 (2003) 820-825
36. Romisch J. Factor VII activating protease (FSAP): a novel protease in hemostasis. Biol Chem 383 (2002) 1119-1124
37. Lane D.A., and Grant P.J. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95 (2000) 1517-1532
38. Ghiu I.A., Ferrell R.E., Kulaputana O., Phares D.A., and Hagberg J.M. Selected genetic polymorphisms and plasma coagulation factor VII changes with exercise training. J Appl Physiol 96 (2004) 985-990
39. Guimaraes A.H., van Tilburg N.H., Vos H.L., Bertina R.M., and Rijken D.C. Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays. Br J Haematol 124 (2004) 659-665
40. Willeit J., Kiechl S., Weimer T., Mair A., Santer P., Wiedermann C.J., et al. Marburg I polymorphism of factor VII-activating protease: a prominent risk predictor of carotid stenosis. Circulation 107 (2003) 667-670
41. Proctor M.C., Greenfield L.J., Wakefield T.W., and Zajkowski P.J. A clinical comparison of pneumatic compression devices: The basis for selection. J Vasc Surg 34 (2001) 459-464